soul trial oral semaglutide cardiovascular outcomes Abstract 4351008: Comparing in New Users of Versus Other Noninsulin Glucose-Lowering Therapies soul trial oral semaglutide cardiovascular
Description
This trial enrolled 338 adults with obesity and tracked them for 48 weeks across multiple dose groups
doi: 10.1002/dmrr.3353 12 VermaSMcMurrayJJV
PMID: 32213703 | doi:10.1172/jci.insight.133429 Kruse T et al
We'll schedule your follow-up to monitor progress
Indikationen fr die Anwendung von GLP Formula GLP Formula wird hufig im Rahmen eines aktiven Gewichtsmanagements eingesetzt
10.1016/j.soard.2019.06.026 57
